Biological Safety Testing Products and Services Market Size, Share & Forecast by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Biological Safety Testing Products and Services Market Size Analysis

Global Biological Safety Testing Products and Services Market Introduction
By Product
1. Introduction
  1. Product By Value
2. Reagents & Kits
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Vaccines & Therapeutics
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Monoclonal Antibodies
    1. Monoclonal Antibodies By Value
  4. Recombinant Protein
    1. Recombinant Protein By Value
3. Blood & Blood-based Products
  1. By Value
4. Gene Therapy
  1. By Value
5. Tissue & Tissue-based Products
  1. By Value
6. Stem Cell
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Endotoxin Tests
  1. By Value
3. Sterility Tests
  1. By Value
4. Cell Line Authentication & Characterization Tests
  1. By Value
5. Bioburden Tests
  1. By Value
6. Adventitious Agent Detection Tests
  1. By Value
7. Residual Host Contamination Detection Tests
  1. By Value
8. Others
  1. By Value

North America Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Reagents & Kits
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Vaccines & Therapeutics
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Monoclonal Antibodies
    1. Monoclonal Antibodies By Value
  4. Recombinant Protein
    1. Recombinant Protein By Value
3. Blood & Blood-based Products
  1. By Value
4. Gene Therapy
  1. By Value
5. Tissue & Tissue-based Products
  1. By Value
6. Stem Cell
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Endotoxin Tests
  1. By Value
3. Sterility Tests
  1. By Value
4. Cell Line Authentication & Characterization Tests
  1. By Value
5. Bioburden Tests
  1. By Value
6. Adventitious Agent Detection Tests
  1. By Value
7. Residual Host Contamination Detection Tests
  1. By Value
8. Others
  1. By Value
U.S.
1. By Product
  1. Introduction
    1. Product By Value
  2. Reagents & Kits
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Vaccines & Therapeutics
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Monoclonal Antibodies
      1. Monoclonal Antibodies By Value
    4. Recombinant Protein
      1. Recombinant Protein By Value
  3. Blood & Blood-based Products
    1. By Value
  4. Gene Therapy
    1. By Value
  5. Tissue & Tissue-based Products
    1. By Value
  6. Stem Cell
    1. By Value
3. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Endotoxin Tests
    1. By Value
  3. Sterility Tests
    1. By Value
  4. Cell Line Authentication & Characterization Tests
    1. By Value
  5. Bioburden Tests
    1. By Value
  6. Adventitious Agent Detection Tests
    1. By Value
  7. Residual Host Contamination Detection Tests
    1. By Value
  8. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Reagents & Kits
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Vaccines & Therapeutics
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Monoclonal Antibodies
    1. Monoclonal Antibodies By Value
  4. Recombinant Protein
    1. Recombinant Protein By Value
3. Blood & Blood-based Products
  1. By Value
4. Gene Therapy
  1. By Value
5. Tissue & Tissue-based Products
  1. By Value
6. Stem Cell
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Endotoxin Tests
  1. By Value
3. Sterility Tests
  1. By Value
4. Cell Line Authentication & Characterization Tests
  1. By Value
5. Bioburden Tests
  1. By Value
6. Adventitious Agent Detection Tests
  1. By Value
7. Residual Host Contamination Detection Tests
  1. By Value
8. Others
  1. By Value
U.K.
1. By Product
  1. Introduction
    1. Product By Value
  2. Reagents & Kits
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Vaccines & Therapeutics
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Monoclonal Antibodies
      1. Monoclonal Antibodies By Value
    4. Recombinant Protein
      1. Recombinant Protein By Value
  3. Blood & Blood-based Products
    1. By Value
  4. Gene Therapy
    1. By Value
  5. Tissue & Tissue-based Products
    1. By Value
  6. Stem Cell
    1. By Value
3. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Endotoxin Tests
    1. By Value
  3. Sterility Tests
    1. By Value
  4. Cell Line Authentication & Characterization Tests
    1. By Value
  5. Bioburden Tests
    1. By Value
  6. Adventitious Agent Detection Tests
    1. By Value
  7. Residual Host Contamination Detection Tests
    1. By Value
  8. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Reagents & Kits
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Vaccines & Therapeutics
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Monoclonal Antibodies
    1. Monoclonal Antibodies By Value
  4. Recombinant Protein
    1. Recombinant Protein By Value
3. Blood & Blood-based Products
  1. By Value
4. Gene Therapy
  1. By Value
5. Tissue & Tissue-based Products
  1. By Value
6. Stem Cell
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Endotoxin Tests
  1. By Value
3. Sterility Tests
  1. By Value
4. Cell Line Authentication & Characterization Tests
  1. By Value
5. Bioburden Tests
  1. By Value
6. Adventitious Agent Detection Tests
  1. By Value
7. Residual Host Contamination Detection Tests
  1. By Value
8. Others
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Reagents & Kits
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Vaccines & Therapeutics
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Monoclonal Antibodies
      1. Monoclonal Antibodies By Value
    4. Recombinant Protein
      1. Recombinant Protein By Value
  3. Blood & Blood-based Products
    1. By Value
  4. Gene Therapy
    1. By Value
  5. Tissue & Tissue-based Products
    1. By Value
  6. Stem Cell
    1. By Value
3. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Endotoxin Tests
    1. By Value
  3. Sterility Tests
    1. By Value
  4. Cell Line Authentication & Characterization Tests
    1. By Value
  5. Bioburden Tests
    1. By Value
  6. Adventitious Agent Detection Tests
    1. By Value
  7. Residual Host Contamination Detection Tests
    1. By Value
  8. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Reagents & Kits
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Vaccines & Therapeutics
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Monoclonal Antibodies
    1. Monoclonal Antibodies By Value
  4. Recombinant Protein
    1. Recombinant Protein By Value
3. Blood & Blood-based Products
  1. By Value
4. Gene Therapy
  1. By Value
5. Tissue & Tissue-based Products
  1. By Value
6. Stem Cell
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Endotoxin Tests
  1. By Value
3. Sterility Tests
  1. By Value
4. Cell Line Authentication & Characterization Tests
  1. By Value
5. Bioburden Tests
  1. By Value
6. Adventitious Agent Detection Tests
  1. By Value
7. Residual Host Contamination Detection Tests
  1. By Value
8. Others
  1. By Value
UAE
1. By Product
  1. Introduction
    1. Product By Value
  2. Reagents & Kits
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Vaccines & Therapeutics
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Monoclonal Antibodies
      1. Monoclonal Antibodies By Value
    4. Recombinant Protein
      1. Recombinant Protein By Value
  3. Blood & Blood-based Products
    1. By Value
  4. Gene Therapy
    1. By Value
  5. Tissue & Tissue-based Products
    1. By Value
  6. Stem Cell
    1. By Value
3. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Endotoxin Tests
    1. By Value
  3. Sterility Tests
    1. By Value
  4. Cell Line Authentication & Characterization Tests
    1. By Value
  5. Bioburden Tests
    1. By Value
  6. Adventitious Agent Detection Tests
    1. By Value
  7. Residual Host Contamination Detection Tests
    1. By Value
  8. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Reagents & Kits
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Vaccines & Therapeutics
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Monoclonal Antibodies
    1. Monoclonal Antibodies By Value
  4. Recombinant Protein
    1. Recombinant Protein By Value
3. Blood & Blood-based Products
  1. By Value
4. Gene Therapy
  1. By Value
5. Tissue & Tissue-based Products
  1. By Value
6. Stem Cell
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Endotoxin Tests
  1. By Value
3. Sterility Tests
  1. By Value
4. Cell Line Authentication & Characterization Tests
  1. By Value
5. Bioburden Tests
  1. By Value
6. Adventitious Agent Detection Tests
  1. By Value
7. Residual Host Contamination Detection Tests
  1. By Value
8. Others
  1. By Value
Brazil
1. By Product
  1. Introduction
    1. Product By Value
  2. Reagents & Kits
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Vaccines & Therapeutics
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Monoclonal Antibodies
      1. Monoclonal Antibodies By Value
    4. Recombinant Protein
      1. Recombinant Protein By Value
  3. Blood & Blood-based Products
    1. By Value
  4. Gene Therapy
    1. By Value
  5. Tissue & Tissue-based Products
    1. By Value
  6. Stem Cell
    1. By Value
3. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Endotoxin Tests
    1. By Value
  3. Sterility Tests
    1. By Value
  4. Cell Line Authentication & Characterization Tests
    1. By Value
  5. Bioburden Tests
    1. By Value
  6. Adventitious Agent Detection Tests
    1. By Value
  7. Residual Host Contamination Detection Tests
    1. By Value
  8. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Biological Safety Testing Products and Services Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Charles River Laboratories
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
BSL Bioservice
Merck KGaA (MilliporeSigma)
Samsung Biologics
Sartorius AG
Bio-Rad Laboratories
CN Bio
Eurofins Scientific
SGS Société Générale de Surveillance SA
Thermo Fisher Scientific Inc.
BIOMÉRIEUX
Lonza
EQUASHIELD

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment